End-of-life anticancer treatment – a nationwide registry-based study of trends in the use of chemo-, endocrine, immune-, and targeted therapies-Reference-Cited by-同舟云学术

End-of-life anticancer treatment – a nationwide registry-based study of trends in the use of chemo-, endocrine, immune-, and targeted therapies

Published:2021-03-02 Issue:8 Volume:60 Page:961-967
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Mattsson Thea Otto¹²,Pottegård Anton³,Jørgensen Trine Lembrecht¹²⁴^ORCID,Green Anders⁵,Bliddal Mette⁵

Affiliation:

1. Department of Oncology, Odense University Hospital, Odense, Denmark

2. AgeCare, Academy of Geriatric Cancer Research, Odense University Hospital, Odense, Denmark

3. Department of Public Health, Division of Clinical Pharmacology and Pharmacy, University of Southern Denmark, Odense, Denmark

4. Institute of Clinical Research, University of Southern Denmark, Odense, Denmark

5. OPEN – Open Patient data Explorative Network, Department of Clinical Research, University of Southern Denmark, and Odense University Hospital, Odense, Denmark

Publisher

Informa UK Limited

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/0284186X.2021.1890332

Reference42 articles.

1. Chemotherapy Use, Performance Status, and Quality of Life at the End of Life

2. Is specialized palliative cancer care associated with use of antineoplastic treatment at the end of life? A population-based cohort study

3. Associations between palliative chemotherapy and adult cancer patients' end of life care and place of death: prospective cohort study

4. Preference for place-of-death among terminally ill cancer patients in Denmark

5. Preferences for place of care and place of death among informal caregivers of the terminally ill

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endocrine treatment near the end of life among older women with metastatic breast cancer: a nationwide cohort study;Frontiers in Oncology;2023-10-09

2. Systemic Anticancer Treatment Near the End of Life: a Narrative Literature Review;Current Treatment Options in Oncology;2023-07-27

3. The prevalence of end-of-life chemotherapy and targeted therapy in Japan, assessed using a health claims database;Cancer Chemotherapy and Pharmacology;2023-05-08

4. Potential overtreatment in end-of-life care in adults 65 years or older dying from cancer: applying quality indicators on nationwide registries;Acta Oncologica;2022-12-02

5. Thirty-Day Mortality Following Systemic Anticancer Therapy: Evaluating Risk Factors Without Selection Bias in a Real-World, Population-Based Cohort From 2009 to 2019;Clinical Oncology;2022-08